Deep domain expertise, a wealth of operational expertise and knowledge gained by helping our investee partners differentiate- this best defines us.

Ramesh Alur
Ramesh Alur
General Partner

Ramesh is a General Partner primarily overseeing the Ventureast Life Fund III and the Biotechnology Venture Fund. He has been with Ventureast for over 15 years, and was part of the APIDC team prior to its partnership with Ventureast. Ramesh has been involved with more than 50 investments across sectors, many of which have realized unprecedented returns. He works closely with early-stage to growth-stage companies in pharmaceuticals, specialty chemicals, manufacturing, infrastructure services, healthcare, dairy products, and alternative fuels.

Having seen the complete cycle of fund raising, investments, and exits while at Ventureast, Ramesh approaches venture funding by working patiently with entrepreneurs through their highs and lows till success is achieved. Ramesh identifies and tracks entrepreneurs much before their funding requirements arise. He tracked the promoters of EP Industries, one of his portfolio companies, for more than three years before the investment was made. Similarly, he tracked Gland Pharma for two years before their investment requirements arose.                

Prior to joining Ventureast, Ramesh worked with APIDC, with Bakelite Hylam, a manufacturer of laminates, and with the prestigious Bhabha Atomic Research Centre. During his time at Bakelite Hylam, he was responsible for restarting, operating, and turning around a sick raw material manufacturer which was newly acquired.

Ramesh is a director on the boards of more than10 companies, which include portfolio companies as well as group companies of Ventureast. He completed his graduate studies in chemical engineering at REC Warangal, and his MBA at the Indian Institute of Management, Bangalore. Ramesh keeps a disarmingly cool temperament, and is an avid practitioner of yoga.

Investments managed by
Ramesh Alur
Learn More

Global pharma major, built from 2.5 crores sales at time of investment to $1.35 billion acquisition by Chinese major.

learn more
Latest News For
Ramesh Alur

No items found.